Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency

Diletta Giovenale1, Cristina Meazza, Giuliana M Cardinale

  • 1Department of Pediatric Science, Università degli Studi di Pavia, Fondazione IRCCS San Matteo, Pavia, Italy.

Insights

Growth hormone (GH) therapy effectively promotes catch-up growth in children with celiac disease (CD) and GH deficiency (GHD) on a gluten-free diet. The treatment

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Metabolic Disorders

Background:

  • Celiac disease (CD) can be associated with growth hormone deficiency (GHD), impacting linear growth in children.
  • Adequate gluten-free diet (GFD) adherence is crucial for managing CD but may not always restore normal growth in GHD patients.
  • Evaluating growth response to GH therapy in CD with GHD is essential for optimizing treatment strategies.

Purpose of the Study:

  • To assess the efficacy of growth hormone (GH) replacement therapy in prepubertal children with celiac disease (CD) and GH deficiency (GHD).
  • To compare the growth response in CD/GHD patients on a gluten-free diet with those having idiopathic GHD (IGHD).

Main Methods:

  • A cohort of 14 prepubertal children with CD and GHD, unresponsive to GFD alone, were studied.
  • 10 age-matched children with idiopathic GHD (IGHD) served as a control group.
  • All participants received a standardized weekly dose of GH (0.25 mg/kg) for three years, with regular monitoring of height, growth rate, and BMI.

Main Results:

  • GH therapy significantly increased growth rates in the first year for both CD/GHD and IGHD groups (P < 0.005).
  • Growth rates remained positive in the third year, indicating sustained catch-up growth in both cohorts.
  • The growth response to GH treatment was comparable between children with CD/GHD on a GFD and those with IGHD.

Conclusions:

  • GH replacement therapy is recommended for children with CD and GHD who do not achieve catch-up growth on a gluten-free diet.
  • GH treatment demonstrates comparable efficacy in promoting growth in CD/GHD patients adhering to a GFD as in IGHD patients.
  • This suggests that GH therapy is a viable option for optimizing growth outcomes in this specific pediatric population.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.